Announcement on the Approval of the Marketing Authorization Application for Sitagliptin Fumarate Tablets (SPH3127 Tablets)

About this update from Shanghai Pharmaceuticals Holding Co. Ltd. Class A

Announcement on the Approval of the Marketing Authorization Application for Sitagliptin Fumarate Tablets (SPH3127 Tablets) The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Pharmaceuticals Holding Co. Ltd. Class A